Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventMar 13, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 10, 2014View HTMLDownload DOCDownload PDF
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Mar 6, 2014View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 6, 2014View HTMLDownload DOCDownload PDFDownload XLS
FWPFree Writing ProspectusMar 5, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 5, 2014View HTMLDownload DOCDownload PDF
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Mar 4, 2014View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventFeb 27, 2014View HTMLDownload DOCDownload PDFDownload XLS
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 26, 2014View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesFeb 24, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 24, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 18, 2014View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventFeb 18, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2014View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2014View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2014View HTMLDownload DOCDownload PDFDownload XLS
5Annual filing director officer or owner of more than ten percent.Feb 14, 2014View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2014View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2014View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-137

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information